Is LMT stock a buy after record F-35 deliveries?

The production beat and Lot 18–19 deal support multi-year volume, services pull-through, and defense backlog growth. That is positive for cash visibility. However, shares trade at about 30x earnings with overbought technicals. Many analysts rate it Hold. Waiting for earnings on 29 January to assess guidance may improve entry discipline.

How do Lots 18–19 affect revenue visibility?

These lots cover up to 296 F-35s worth about $24 billion, supporting predictable Aeronautics revenue and supplier stability. Larger blocks often reduce unit costs and improve scheduling. Added international orders can extend the run-rate and bolster sustainment demand, lifting long-term cash flows tied to upgrades, training, and parts.

What risks should Indian investors consider with LMT stock?

Key risks include US budget outcomes, timing of TR-3 fielding, supplier bottlenecks, and potential cost inflation. Valuation is elevated versus history, so sentiment can swing on guidance. INR-USD moves also affect returns for India-based investors using LRS or international funds, given all cash flows settle in USD.

How can investors in India buy LMT stock?

Investors can use international brokers under RBI’s Liberalised Remittance Scheme, which permits up to USD 250,000 per financial year, or consider global mutual funds and ETFs that hold defense names. Review brokerage fees, forex spreads, and tax rules before investing, as these can materially impact net returns.

Global Market Insights

LMT Stock Today: January 11 — Record F-35 Deliveries, $24B Lots Lift Outlook

ByDanny Kontos January 11, 2026January 11, 2026

LMT stock is in focus after Lockheed Martin (LMT) reported a record 191 F-35 deliveries for 2025 and sealed a $24 billion Lot 18–19 agreement for up to 296 jets. The deal, plus reports of TR-3 software deployment and active combat use, points to stronger program maturity and defense backlog growth. For Indian investors using global platforms, this supports a durable US defense exposure. Shares last traded at $511.57, down 1.33% on the day, with Q4 results due 29 January 2026.